These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19095373)

  • 1. Target definition by C11-methionine-PET for the radiotherapy of brain metastases.
    Matsuo M; Miwa K; Shinoda J; Kako N; Nishibori H; Sakurai K; Yano H; Iwama T; Kanematsu M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):714-22. PubMed ID: 19095373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas.
    Astner ST; Dobrei-Ciuchendea M; Essler M; Bundschuh RA; Sai H; Schwaiger M; Molls M; Weber WA; Grosu AL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1161-7. PubMed ID: 18440729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
    Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of [¹¹C]methionine PET for stereotactic radiation therapy with intensity modulated radiation therapy to metastatic brain tumors.
    Miwa K; Matsuo M; Shinoda J; Aki T; Yonezawa S; Ito T; Asano Y; Yamada M; Yokoyama K; Yamada J; Yano H; Iwama T
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1139-44. PubMed ID: 22520479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Astner ST; Adam M; Krause BJ; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):339-44. PubMed ID: 16765533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
    Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
    J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma.
    Navarria P; Reggiori G; Pessina F; Ascolese AM; Tomatis S; Mancosu P; Lobefalo F; Clerici E; Lopci E; Bizzi A; Grimaldi M; Chiti A; Simonelli M; Santoro A; Bello L; Scorsetti M
    Radiother Oncol; 2014 Sep; 112(3):425-9. PubMed ID: 25308182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
    Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
    Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings?
    Wu K; Ung YC; Hornby J; Freeman M; Hwang D; Tsao MS; Dahele M; Darling G; Maziak DE; Tirona R; Mah K; Wong CS
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):699-706. PubMed ID: 19836163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
    Popp I; Bott S; Mix M; Oehlke O; Schimek-Jasch T; Nieder C; Nestle U; Bock M; Yuh WTC; Meyer PT; Weber WA; Urbach H; Mader I; Grosu AL
    Radiother Oncol; 2019 Jan; 130():121-131. PubMed ID: 30219612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
    J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation treatment planning in brain tumours: potential impact of 3-O-methyl-6-[(18)F]fluoro-L-DOPA and PET.
    Alheit H; Oehme L; Winkler C; Füchtner F; Hoepping A; Grabowski J; Kotzerke J; Beuthien-Baumann B
    Nuklearmedizin; 2008; 47(5):200-4. PubMed ID: 18852926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.